“We plant, grow and cultivate technology companies.”

Who we are and What we do

Astute Capital specializes in managing, advising and investing in small, public and private high-growth technology companies. We are long term investors. Our objectives are Capital Appreciation as well as Capital Preservation. What we do is high risk. The investments we manage are initially highly illiquid and volatile. Drawdowns can be large.

Investment in our Funds involves long-term patience and an appetite for managed risk. It is not for the average investor.

Strategy

Astute Capital makes investments across the global technology industry, from seed-stage venture capital to large publicly-traded companies. Investments are made in one of three strategies: public equity, private equity, and private credit/royalty.

Public Equity

Astute Capital manages a series of public equity funds, including long/short event-driven funds and closed-end investment trusts. We invest across all types of publicly-traded companies, from biopharmaceuticals to medical devices and healthcare services worldwide..

Private Equity/Venture

Astute Capital’s private equity strategy is broad and flexible, investing from start-ups through growth equity. Astute Capital is typically a lead investor, seeking to help build our portfolio companies. Our geographic focus includes North America, Asia, Europe and Israel.

Private Credit/Royalty

Astute Capital provides commercial-stage healthcare companies with non-dilutive structured debt capital. Additionally, Astute Capital can monetize royalty streams, providing valuable financing solutions to owners of intellectual property.